spacer
home > white papers > Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor - Eppendorf
WHITE PAPERS
logo_Eppendorf5.jpg

Eppendorf

phone +49 2461 980 400
email bioprocess-info@eppendorf.de
web http://www.eppendorf.com
email Bioprocess Center Europe, Rudolf Schulten Str 5, 52428 Juelich

Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor

The number of bioprocess applications for microalgae has increased in recent years, particularly in the fi eld of biofuel production. The combination of the New Brunswick CelliGen 310 stirred-tank bioreactor and the DASGIP LED Illumination System creates a bioreactor setup which is capable of supporting high density microalgal growth. Using the stand-alone Eppendorf DASGIP PBR4 Module, LED illumination spectra and intensities can be controlled for optimal support of all types of chlorophylls and carotenoids. For this study in which high density culture of up to 1.5 x 107 cells/mL was achieved, the unicellular freshwater alga, Dunaliella tertiolecta, was used.
Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Micro dosing pumps in global use against COVID-19

(PresseBox) ( Schwerin, 24.06.20 ) Automated analysis devices are the essential basis for extensive test capacities for the corona virus. Through parallel and faster processes, automation significantly increases the number of tests, saves manpower and ensures process reliability. For sample preparation for SARS-CoV-2, a few microliters of a solution of chemicals and enzymes are dosed. Micro annular gear pumps of the low pressure series from HNP Mikrosysteme perform this demanding task with highest precision and process reliability. The minimum dosing quantity is 0.25 µl, the pumps have a very small footprint and can be easily integrated into control systems. Fully automated analysis devices can contain up to sixteen dosing pumps and can handle up to 4,000 samples in 24 hours.
More info >>


White Papers

Device Develop for Combo Products

Phillips-Medisize

Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >>


Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement